Medicenna Therapeutics Corp.
TSX:MDNA
C$ 2.27
C$0.00 (0.00%)
C$ 2.27
C$0.00 (0.00%)
End-of-day quote: 05/17/2024

MDNA - Medicenna Therapeutics Stock Prediction 2025 - 2030

7 years of reliable Medicenna Therapeutics stock forecast. The Wall Street analysts predict Buy for MDNA. See at a glance whether TSX:MDNA will rise in the future.

Forecast 2023
C$0.00 C$2.45
Forecast 2025
C$3.84
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
C$0.00 C$2.45
Forecast 2030
C$3.84
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
1.29
Price-to-book Ratio
8.41
Market Cap
0.07B
TEV
0.05 B
Dividend
C$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
C$6.30
Country

Medicenna Therapeutics Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Medicenna Therapeutics Stock Forecast 2023

C$7.00

In the last five quarters, Medicenna Therapeutics’s Price Target has fallen from C$7.80 to C$6.30 - a -19.23% decrease.

208.37%
208.37
Last update: 05/20/2024

Highest Price Target C$9.00

Average Price Target C$7.00

Lowest Price Target C$5.00

Medicenna Therapeutics Stock Prediction 2025

Medicenna Therapeutics Stock Forecast 2030

Stock Forecast for the Price of an Medicenna Therapeutics Share in Jan 2030.

In January 2030, analysts believe the stock price will be C$3.78. An increase of 66.61% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Feb 2030.

In February 2030, analysts believe the stock price will be C$3.81. An increase of 67.82% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Mar 2030.

In March 2030, analysts believe the stock price will be C$3.84. An increase of 69.02% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Apr 2030.

In April 2030, analysts believe the stock price will be C$3.87. An increase of 70.34% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in May 2030.

In May 2030, analysts believe the stock price will be C$3.90. An increase of 71.66% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Jun 2030.

In June 2030, analysts believe the stock price will be C$3.93. An increase of 72.98% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Jul 2030.

In July 2030, analysts believe the stock price will be C$3.96. An increase of 74.3% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Aug 2030.

In August 2030, analysts believe the stock price will be C$3.99. An increase of 75.62% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Sep 2030.

In September 2030, analysts believe the stock price will be C$4.02. An increase of 76.94% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Oct 2030.

In October 2030, analysts believe the stock price will be C$4.05. An increase of 78.25% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Nov 2030.

In November 2030, analysts believe the stock price will be C$4.08. An increase of 79.57% compared to the previous month's estimate.

Stock Forecast for the Price of an Medicenna Therapeutics Share in Dec 2030.

In December 2030, analysts believe the stock price will be C$4.11. An increase of 80.89% compared to the previous month's estimate.

P/E
0.00
Beta
1.29
Price-to-book Ratio
8.41
Market Cap
0.07B
TEV
0.05 B
Dividend
C$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
C$6.30
Country

Medicenna Therapeutics Analyst Ratings Frequently Asked Questions

Who are the analysts watching Medicenna Therapeutics Corp.?

The following analysts have recently covered Medicenna Therapeutics:

Bloom Burton & Co.
H.C. Wainwright & Co.
Research Capital Corporation
Zacks Small-Cap Research
JonesTrading Institutional Services, LLC
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Medicenna Therapeutics Corp.?

The following sell-side analysts have recently covered Medicenna Therapeutics:

Martin, David C.
Ramakanth, Swayampakula
Uddin, Andre
Bautz, David
Novack, Catherine Clare
(This information refers to the last 90 days.)